世界の組換えタンパク質ワクチン産業調査2019-2025

• 英文タイトル：Global Recombinant Protein Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

• レポートコード：QYR9NV16912 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※本調査レポートでは、世界の組換えタンパク質ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えタンパク質ワクチンの種類別には、細菌細胞培養、哺乳類細胞培養に、用途別には、人間、動物に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・組換えタンパク質ワクチンの種類別市場規模：細菌細胞培養、哺乳類細胞培養 ・組換えタンパク質ワクチンの用途別市場規模：人間、動物 ・組換えタンパク質ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences、Novavax、Medicago ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ...

Recombinant Protein Vaccine refers to the vaccines manufactured using recombinant DNA technologyIn 2018, the global Recombinant Protein Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Recombinant Protein Vaccine.

This study researches the market size of Recombinant Protein Vaccine, presents the global Recombinant Protein Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Recombinant Protein Vaccine in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Recombinant Protein Vaccine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Novavax
Medicago

Market Segment by Product Type
Bacterial Cells Culture
Mammalian Cells Culture

Market Segment by Application
Human
Animal

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Recombinant Protein Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Recombinant Protein Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Recombinant Protein Vaccine are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

レポート目次

---

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Recombinant Protein Vaccine Market Size Growth Rate by Type
1.3.2 Bacterial Cells Culture
1.3.3 Mammalian Cells Culture
1.4 Market Segment by Application
1.4.1 Global Recombinant Protein Vaccine Market Share by Application (2019-2025)
1.4.2 Human
1.4.3 Animal
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Recombinant Protein Vaccine Market Size
2.1.1 Global Recombinant Protein Vaccine Revenue 2014-2025
2.1.2 Global Recombinant Protein Vaccine Sales 2014-2025
2.2 Recombinant Protein Vaccine Growth Rate by Regions
2.2.1 Global Recombinant Protein Vaccine Sales by Regions 2014-2019
2.2.2 Global Recombinant Protein Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Recombinant Protein Vaccine Sales by Manufacturers
3.1.1 Recombinant Protein Vaccine Sales by Manufacturers 2014-2019
3.1.2 Recombinant Protein Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Recombinant Protein Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Protein Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Recombinant Protein Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Recombinant Protein Vaccine Price by Manufacturers
3.4 Key Manufacturers Recombinant Protein Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Recombinant Protein Vaccine Market
3.6 Key Manufacturers Recombinant Protein Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Bacterial Cells Culture Sales and Revenue (2014-2019)
4.1.2 Mammalian Cells Culture Sales and Revenue (2014-2019)
4.2 Global Recombinant Protein Vaccine Sales Market Share by Type
4.3 Global Recombinant Protein Vaccine Revenue Market Share by Type
4.4 Recombinant Protein Vaccine Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Recombinant Protein Vaccine Sales by Application

6 North America
6.1 North America Recombinant Protein Vaccine Breakdown Data by Company
6.2 North America Recombinant Protein Vaccine Breakdown Data by Type
6.3 North America Recombinant Protein Vaccine Breakdown Data by Application
6.4 North America Recombinant Protein Vaccine Breakdown Data by Countries
6.4.1 North America Recombinant Protein Vaccine Sales by Countries
6.4.2 North America Recombinant Protein Vaccine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Recombinant Protein Vaccine Breakdown Data by Company
7.2 Europe Recombinant Protein Vaccine Breakdown Data by Type
7.3 Europe Recombinant Protein Vaccine Breakdown Data by Application
7.4 Europe Recombinant Protein Vaccine Breakdown Data by Countries
7.4.1 Europe Recombinant Protein Vaccine Sales by Countries
7.4.2 Europe Recombinant Protein Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Recombinant Protein Vaccine Breakdown Data by Company
8.2 Asia Pacific Recombinant Protein Vaccine Breakdown Data by Type
8.3 Asia Pacific Recombinant Protein Vaccine Breakdown Data by Application
8.4 Asia Pacific Recombinant Protein Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Recombinant Protein Vaccine Sales by Countries
8.4.2 Asia Pacific Recombinant Protein Vaccine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Recombinant Protein Vaccine Breakdown Data by Company
9.2 Central & South America Recombinant Protein Vaccine Breakdown Data by Type
9.3 Central & South America Recombinant Protein Vaccine Breakdown Data by Application
9.4 Central & South America Recombinant Protein Vaccine Breakdown Data by Countries
9.4.1 Central & South America Recombinant Protein Vaccine Sales by Countries
9.4.2 Central & South America Recombinant Protein Vaccine Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Recombinant Protein Vaccine Breakdown Data by Type
10.2 Middle East and Africa Recombinant Protein Vaccine Breakdown Data by Application
10.3 Middle East and Africa Recombinant Protein Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Recombinant Protein Vaccine Sales by Countries
10.3.2 Middle East and Africa Recombinant Protein Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.1.4 Recombinant Protein Vaccine Product Introduction
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.2.4 Recombinant Protein Vaccine Product Introduction
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.3.4 Recombinant Protein Vaccine Product Introduction
11.3.5 Sanofi Recent Development
11.4 Zoties
11.4.1 Zoties Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.4.4 Recombinant Protein Vaccine Product Introduction
11.4.5 Zoties Recent Development
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.5.4 Recombinant Protein Vaccine Product Introduction
11.5.5 Elanco Recent Development
11.6 Boehringer-Ingelheim
11.6.1 Boehringer-Ingelheim Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.6.4 Recombinant Protein Vaccine Product Introduction
11.6.5 Boehringer-Ingelheim Recent Development
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.7.4 Recombinant Protein Vaccine Product Introduction
11.7.5 Indian Immunologicals Recent Development
11.8 Plumbline Life Sciences
11.8.1 Plumbline Life Sciences Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.8.4 Recombinant Protein Vaccine Product Introduction
11.8.5 Plumbline Life Sciences Recent Development
11.9 Novavax
11.9.1 Novavax Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.9.4 Recombinant Protein Vaccine Product Introduction
11.9.5 Novavax Recent Development
11.10 Medicago
11.10.1 Medicago Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Recombinant Protein Vaccine
11.10.4 Recombinant Protein Vaccine Product Introduction
11.10.5 Medicago Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Recombinant Protein Vaccine Sales Channels
12.2.2 Recombinant Protein Vaccine Distributors
12.3 Recombinant Protein Vaccine Customers

13 Market Forecast
13.1 Global Recombinant Protein Vaccine Sales and Revenue Forecast 2019-2025
13.2 Global Recombinant Protein Vaccine Sales Forecast by Type
13.3 Global Recombinant Protein Vaccine Sales Forecast by Application
13.4 Recombinant Protein Vaccine Forecast by Regions
13.4.1 Global Recombinant Protein Vaccine Sales Forecast by Regions 2019-2025
13.4.2 Global Recombinant Protein Vaccine Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Recombinant Protein Vaccine Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Recombinant Protein Vaccine Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Recombinant Protein Vaccine Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Recombinant Protein Vaccine Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Recombinant Protein Vaccine Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Recombinant Protein Vaccine Product Picture
Table Recombinant Protein Vaccine Key Market Segments
Table Major Manufacturers Recombinant Protein Vaccine Covered in This Report
Table Global Recombinant Protein Vaccine Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Recombinant Protein Vaccine Sales Market Shar by Type 2014-2025
Figure Bacterial Cells Culture Figures
Table Major Manufacturers of Bacterial Cells Culture
Figure Mammalian Cells Culture Figures
Table Major Manufacturers of Mammalian Cells Culture
Table Global Recombinant Protein Vaccine Market Share by Application 2019-2025 (K Units)
Figure Human Use Case
Figure Animal Use Case
Figure Recombinant Protein Vaccine Report Years Considered
Figure Global Recombinant Protein Vaccine Market Size 2014-2025 (Million US$)
Figure Global Recombinant Protein Vaccine Sales 2014-2019 (K Units)
Table Global Recombinant Protein Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Recombinant Protein Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Recombinant Protein Vaccine Sales Market Share by Regions 2014-2019
Figure Global Recombinant Protein Vaccine Sales Market Share by Regions 2014-2019
Figure Global Recombinant Protein Vaccine Sales Market Share by Regions in 2018
Table Global Recombinant Protein Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Recombinant Protein Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Protein Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Protein Vaccine Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Recombinant Protein Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Recombinant Protein Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Recombinant Protein Vaccine Sales Share by Manufacturers in 2018
Table Recombinant Protein Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Recombinant Protein Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Recombinant Protein Vaccine Value Share by Manufacturers in 2018
Table Global Recombinant Protein Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Recombinant Protein Vaccine Price (2014-2019) (USD/Unit)
Table Key Manufacturers Recombinant Protein Vaccine Plants/Factories Distribution
Table Key Manufacturers Recombinant Protein Vaccine Area Served
Table Date of Key Manufacturers Enter into Recombinant Protein Vaccine Market
Table Key Manufacturers Recombinant Protein Vaccine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Bacterial Cells Culture Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Mammalian Cells Culture Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Recombinant Protein Vaccine Sales by Type (2014-2019) (K Units)
Table Global Recombinant Protein Vaccine Sales Share by Type (2014-2019)
Figure Global Recombinant Protein Vaccine Sales Market Share by Type (2014-2019)
Figure Global Recombinant Protein Vaccine Sales Market Share by Type in 2018
Table Global Recombinant Protein Vaccine Revenue by Type (2014-2019) (Million US$)
Table Global Recombinant Protein Vaccine Revenue Share by Type (2014-2019)
Figure Global Recombinant Protein Vaccine Revenue Market Share by Type (2014-2019)
Figure Global Recombinant Protein Vaccine Revenue Market Share by Type in 2018
Table Recombinant Protein Vaccine Price by Type 2014-2019 (USD/Unit)
Table Global Recombinant Protein Vaccine Sales by Application (2014-2019) (K Units)
Table Global Recombinant Protein Vaccine Sales Share by Application (2014-2019)
Figure Global Sales Recombinant Protein Vaccine Market Share by Application (2014-2019)
Figure Global Sales Recombinant Protein Vaccine Market Share by Application in 2018
Figure North America Recombinant Protein Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Recombinant Protein Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Recombinant Protein Vaccine Sales by Company (2014-2019) (K Units)
Table North America Recombinant Protein Vaccine Sales Market Share by Company (2014-2019)
Figure North America Recombinant Protein Vaccine Sales Market Share by Company in 2018
Table North America Recombinant Protein Vaccine Sales by Type (2014-2019) (K Units)
Table North America Recombinant Protein Vaccine Sales Market Share by Type (2014-2019)
Figure North America Recombinant Protein Vaccine Market Share by Type in 2018
Table North America Recombinant Protein Vaccine Sales by Application (2014-2019) (K Units)
Table North America Recombinant Protein Vaccine Sales Market Share by Application (2014-2019)
Figure North America Recombinant Protein Vaccine Market Share by Application in 2018
Table North America Recombinant Protein Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Recombinant Protein Vaccine Sales Market Share by Countries in 2018
Table North America Recombinant Protein Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Protein Vaccine Revenue Market Share by Countries in 2018
Figure United States Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Europe Recombinant Protein Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Recombinant Protein Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Recombinant Protein Vaccine Sales by Company (2014-2019) (K Units)
Table Europe Recombinant Protein Vaccine Sales Market Share by Company (2014-2019)
Figure Europe Recombinant Protein Vaccine Sales Market Share by Company in 2018
Table Europe Recombinant Protein Vaccine Sales by Type (2014-2019) (K Units)
Table Europe Recombinant Protein Vaccine Sales Market Share by Type (2014-2019)
Figure Europe Recombinant Protein Vaccine Sales Market Share by Type in 2018
Table Europe Recombinant Protein Vaccine Sales by Application (2014-2019) (K Units)
Table Europe Recombinant Protein Vaccine Sales Market Share by Application (2014-2019)
Figure Europe Recombinant Protein Vaccine Sales Market Share by Application in 2018
Table Europe Recombinant Protein Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure Europe Recombinant Protein Vaccine Sales Market Share by Countries in 2018
Table Europe Recombinant Protein Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure Europe Recombinant Protein Vaccine Revenue Market Share by Countries in 2018
Figure Germany Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Recombinant Protein Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Recombinant Protein Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Recombinant Protein Vaccine Sales by Regions (2014-2019) (K Units)
Table Asia Pacific Recombinant Protein Vaccine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Recombinant Protein Vaccine Sales Market Share by Regions in 2018
Table Asia Pacific Recombinant Protein Vaccine Sales by Type (2014-2019) (K Units)
Table Asia Pacific Recombinant Protein Vaccine Sales Market Share by Type (2014-2019)
Figure Asia Pacific Recombinant Protein Vaccine Market Share by Type in 2018
Table Asia Pacific Recombinant Protein Vaccine Sales by Application (2014-2019) (K Units)
Table Asia Pacific Recombinant Protein Vaccine Sales Market Share by Application (2014-2019)
Figure Asia Pacific Recombinant Protein Vaccine Market Share by Application in 2018
Table Asia Pacific Recombinant Protein Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Recombinant Protein Vaccine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Recombinant Protein Vaccine Sales Market Share by Regions in 2018
Table Asia Pacific Recombinant Protein Vaccine Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Recombinant Protein Vaccine Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Recombinant Protein Vaccine Revenue Market Share by Regions in 2018
Figure China Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Recombinant Protein Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Recombinant Protein Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Recombinant Protein Vaccine Sales by Company (2014-2019) (K Units)
Table Central & South America Recombinant Protein Vaccine Sales Market Share by Company (2014-2019)
Figure Central & South America Recombinant Protein Vaccine Sales Market Share by Company in 2018
Table Central & South America Recombinant Protein Vaccine Sales by Type (2014-2019) (K Units)
Table Central & South America Recombinant Protein Vaccine Sales Market Share by Type (2014-2019)
Figure Central & South America Recombinant Protein Vaccine Market Share by Type in 2018
Table Central & South America Recombinant Protein Vaccine Sales by Application (2014-2019) (K Units)
Table Central & South America Recombinant Protein Vaccine Sales Market Share by Application (2014-2019)
Figure Central & South America Recombinant Protein Vaccine Market Share by Application in 2018
Table Central & South America Recombinant Protein Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure Central & South America Recombinant Protein Vaccine Sales Market Share by Countries in 2018
Table Central & South America Recombinant Protein Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure Central & South America Recombinant Protein Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Recombinant Protein Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Recombinant Protein Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Recombinant Protein Vaccine Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Recombinant Protein Vaccine Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Sales Market Share by Type in 2018
Table Middle East and Africa Recombinant Protein Vaccine Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Recombinant Protein Vaccine Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Sales Market Share by Application in 2018
Table Middle East and Africa Recombinant Protein Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Recombinant Protein Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Recombinant Protein Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Recombinant Protein Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Protein Vaccine Revenue Market Share by Countries in 2018
Figure GCC Countries Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Egypt Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure South Africa Recombinant Protein Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Recombinant Protein Vaccine Revenue Growth Rate (2014-2019) (K Units)
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Merck Recombinant Protein Vaccine Sales Market Share in Global Market
Table Merck Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table GSK Recombinant Protein Vaccine Sales Market Share in Global Market
Table GSK Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Sanofi Recombinant Protein Vaccine Sales Market Share in Global Market
Table Sanofi Recent Development
Table Zoties Company Details
Table Zoties Description and Business Overview
Table Zoties Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zoties Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Zoties Recombinant Protein Vaccine Sales Market Share in Global Market
Table Zoties Recent Development
Table Elanco Company Details
Table Elanco Description and Business Overview
Table Elanco Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Elanco Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Elanco Recombinant Protein Vaccine Sales Market Share in Global Market
Table Elanco Recent Development
Table Boehringer-Ingelheim Company Details
Table Boehringer-Ingelheim Description and Business Overview
Table Boehringer-Ingelheim Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer-Ingelheim Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Boehringer-Ingelheim Recombinant Protein Vaccine Sales Market Share in Global Market
Table Boehringer-Ingelheim Recent Development
Table Indian Immunologicals Company Details
Table Indian Immunologicals Description and Business Overview
Table Indian Immunologicals Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Indian Immunologicals Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Indian Immunologicals Recombinant Protein Vaccine Sales Market Share in Global Market
Table Indian Immunologicals Recent Development
Table Plumbline Life Sciences Company Details
Table Plumbline Life Sciences Description and Business Overview
Table Plumbline Life Sciences Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Plumbline Life Sciences Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Plumbline Life Sciences Recombinant Protein Vaccine Sales Market Share in Global Market
Table Plumbline Life Sciences Recent Development
Table Novavax Company Details
Table Novavax Description and Business Overview
Table Novavax Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novavax Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Novavax Recombinant Protein Vaccine Sales Market Share in Global Market
Table Novavax Recent Development
Table Medicago Company Details
Table Medicago Description and Business Overview
Table Medicago Recombinant Protein Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medicago Recombinant Protein Vaccine Sales Growth Rate (2014-2019)
Table Medicago Recombinant Protein Vaccine Sales Market Share in Global Market
Table Medicago Recent Development
Figure Recombinant Protein Vaccine Value Chain
Table Recombinant Protein Vaccine Distributors List
Table Recombinant Protein Vaccine Customers List
Table Global Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Global Recombinant Protein Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Global Recombinant Protein Vaccine Sales Forecast by Type 2019-2025 (K Units)
Figure Global Recombinant Protein Vaccine Sales Forecast by Type 2019-2025 (K Units)
Figure Global Recombinant Protein Vaccine Sales Market Share Forecast by Type 2019-2025
Table Global Recombinant Protein Vaccine Sales Forecast by Application 2019-2025 (K Units)
Figure Global Recombinant Protein Vaccine Sales Forecast by Application 2019-2025 (K Units)
Figure Global Recombinant Protein Vaccine Sales Market Share Forecast by Application 2019-2025
Table Global Recombinant Protein Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Recombinant Protein Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Recombinant Protein Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Recombinant Protein Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Recombinant Protein Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Recombinant Protein Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table North America Recombinant Protein Vaccine Sales Forecast by Countries 2019-2025 (K Units)
Table North America Recombinant Protein Vaccine Sales Market Share Forecast by Countries 2019-2025
Table North America Recombinant Protein Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Recombinant Protein Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure United States Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Canada Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Mexico Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Table Europe Recombinant Protein Vaccine Sales Forecast by Countries 2019-2025 (K Units)
Table Europe Recombinant Protein Vaccine Sales Market Share Forecast by Countries 2019-2025
Table Europe Recombinant Protein Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Recombinant Protein Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure France Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure UK Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Italy Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Russia Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Table Asia Pacific Recombinant Protein Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Asia Pacific Recombinant Protein Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Recombinant Protein Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Recombinant Protein Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure China Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Japan Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure South Korea Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure India Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Australia Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Indonesia Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Thailand Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Malaysia Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Philippines Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Vietnam Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Table Central & South America Recombinant Protein Vaccine Sales Forecast by Countries 2019-2025 (K Units)
Table Central & South America Recombinant Protein Vaccine Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Recombinant Protein Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Recombinant Protein Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Table Middle East and Africa Recombinant Protein Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Middle East and Africa Recombinant Protein Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Recombinant Protein Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Recombinant Protein Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure GCC Countries Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure Egypt Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Figure South Africa Recombinant Protein Vaccine Sales Forecast 2019-2025 (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---